相关实验视频

Updated: Jun 25, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

维斯纳金:一种新型的心脏保护剂,可以预防人环素的毒性 (评论)

Omar Obeidat^1,2, Ali Obeidat³, Abedallah Obeidat³

¹Graduate Medical Education Program, College of Medicine, University of Central Florida, Orlando, FL 32816, USA.

Medicine international

|May 27, 2024

概括

维斯纳金在保护心脏免受多克索鲁比 (DOX) 化疗损伤方面表现有前途. 这篇评论探讨了Visnagin的情况.

科学领域:

心脏病学心脏病学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

多克索鲁比 (DOX) 化疗会引起剂量依赖的心脏毒性,导致心力衰竭.
目前针对DOX诱导心脏毒性的心脏保护策略的有效性有限.
DOX心脏毒性的机制包括线粒体功能障碍,氧化应激和破坏平衡.

研究的目的:

审查维斯纳金对多克索鲁比辛诱导心脏毒性的心脏保护机制.
提出实验证据支持维斯纳金的疗效.
探索visnagin在癌症治疗方案中的潜在整合.

主要方法:

对维斯纳金和多克索鲁比辛心脏毒性研究的综合文献综述.
对关于维斯纳金对心肌细胞功能影响的实验证据的分析.
对维斯纳金对线粒体保护,信号通路和亡的影响的评估.

主要成果:

维斯纳金证明了对多克索鲁比诱导的心脏毒性的心脏保护作用.
维斯纳金保护线粒体,调节关键信号通路,并抑制心肌细胞的亡.
维斯纳金具有血管扩张和抗炎性质,有助于其心脏保护作用.

结论:

维斯纳金是一种有前途的治疗药物,用于控制多克索鲁比诱导的心脏毒性.
需要进一步的研究和临床试验来证实visnagin在癌症治疗中的作用.
维斯纳金 (Visnagin) 提供了一种潜在的策略,可以减轻接受 antracycline 化疗的患者的心脏损伤.

关键词:

环素是一种环素.癌症化疗癌症化疗心脏保护心脏保护心脏有毒性心脏有毒性德克索鲁比辛 (doxorubicin) 是一种药物.在Visnagin的时候.

更多相关视频

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

Published on: January 7, 2015

相关概念视频

Heart Failure Drugs: Inotropic Agents

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...